Skip to main content
. 2017 Aug 22;6(4):413–421. doi: 10.1007/s13566-017-0326-3

Table 7.

Late toxicities within 1 year of treatment—patients who received mitomycin-C (IMRT 75.4%; 3D-CRT 85.6%)

Number of occurrences
IMRT 3D-CRT
Diarrhea 1 2
Stenosis 1 2
Enterocolitis 0 1
Proctitis 0 5
Anal ulcer 1 1
Fistula 0 1
Wound dehiscence 0 1
Pain 0 4
Total occurrences 3 17
% of patients 6.5 19.1

IMRT intensity-modulated radiation therapy, 3D-CRT 3-dimensional conventional radiation therapy